LPL Financial
OREX

LPL Financial’s Orexigen Therapeutics, Inc. OREX Stock Holding History

LPL Financial’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,085
Closed -$5K – 2829
2016
Q2 		$5K Buy
+1,085
New +$4.91K ﹤0.01% 2614
2015
Q1 		– Sell
-2,044
Closed -$124K – 2931
2014
Q4 		$124K Sell
2,044
-16
-0.8% -$804 ﹤0.01% 2602
2014
Q3 		$83K Buy
2,060
+217
+12% +$11.7K ﹤0.01% 2615
2014
Q2 		$114K Buy
1,843
+266
+17% +$15.5K ﹤0.01% 2586
2014
Q1 		$102K Buy
1,577
+470
+42% +$31.8K ﹤0.01% 2552
2013
Q4 		$62K Buy
+1,107
New +$62.2K ﹤0.01% 2588

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LPL Financial's OREX Position: Q3 2016 in Review

LPL Financial sold out of Orexigen Therapeutics, Inc. (OREX) in Q3 2016, closing a stake of 1,085 shares — an estimated $5K sold.

LPL Financial first reported a position in OREX in Q4 2013 and held it in 6 quarters. The position peaked at $124K in Q4 2014. 55 funds tracked by Wall St. Rank hold OREX as of Q3 2016.

  • LPL Financial reported no remaining Orexigen Therapeutics, Inc. position as of Q3 2016 after selling out during the quarter.
  • LPL Financial sold 1,085 Orexigen Therapeutics, Inc. shares in Q3 2016, an estimated $5K.
  • LPL Financial first reported a position in Orexigen Therapeutics, Inc. in Q4 2013 and held it in 6 quarters.
  • LPL Financial's Orexigen Therapeutics, Inc. position peaked at $124K in Q4 2014.
  • 55 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q3 2016.

Based on LPL Financial's 13F filing for Q3 2016, filed 16 Nov 2016.